Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006468
Filing Date
2024-11-13
Accepted
2024-11-13 16:00:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 EMERGENT BIOSOLUTIONS INC. p24-3235sc13g.htm SC 13G 50794
  Complete submission text file 0000902664-24-006468.txt   52321
Mailing Address 1 VANDERBILT AVE 16TH FLOOR NEW YORK NY 10017
Business Address 1 VANDERBILT AVE 16TH FLOOR NEW YORK NY 10017 212-326-1500
OAK HILL ADVISORS LP (Filed by) CIK: 0001164688 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Subject) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82602 | Film No.: 241453808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)